Mach7 TechnologiesASX:M7T -1.67%35 Market Cap is A$69.33 Mil as of Jun. 28, 2026. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.83 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Mach7 Technologies ranks worse than 60.69% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mach7 Technologies's share price for the quarter that ended in Dec. 2025 was A$0.615. Mach7 Technologies's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 234.97 Mil. Therefore, Mach7 Technologies's market cap for the quarter that ended in Dec. 2025 was A$144.51 Mil.
Mach7 Technologies's quarterly market cap
declined
from Dec. 2024 (A$96.50 Mil) to Jun. 2025 (A$77.54 Mil) but then
increased
from Jun. 2025 (A$77.54 Mil) to Dec. 2025 (A$144.51 Mil).
Mach7 Technologies's annual market cap
increased
from Jun. 2023 (A$148.81 Mil) to Jun. 2024 (A$154.39 Mil) but then
declined
from Jun. 2024 (A$154.39 Mil) to Jun. 2025 (A$77.54 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mach7 Technologies's Enterprise Value for Today is A$51.83 Mil.
Mach7 Technologies (ASX:M7T) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mach7 Technologies Market Cap Related Terms
Mach7 Technologies Market Cap Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Mach7 Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Mach7 Technologies's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mach7 Technologies (ASX:M7T) has a Market Cap of A$69.33 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mach7 Technologies and its competitors. According to the industry distribution chart, Mach7 Technologies ranks #423 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 60.7%.
Is Mach7 Technologies' Market Cap too high?
Mach7 Technologies' current Market Cap is A$69.33 Mil. Based on the distribution chart, Mach7 Technologies ranks #423 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #423 out of 697 companies for Market Cap. This places Mach7 Technologies in the lower half of its industry. The industry median Market Cap is 93.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current Market Cap is A$69.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.83, compared to a current price of A$0.30 — trading 64.5% below its estimated fair value. The current Market Cap is A$69.33 Mil. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current Market Cap is A$69.33 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of A$0.30 is trading 64.5% below its estimated GF Value™ of A$0.83.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for ASX:M7T:
Market Cap: A$69.33 Mil
GF Value™: A$0.83 vs. price of A$0.30 (64.5% below fair value)
No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score
Get the complete analysis for ASX:M7T
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:M7T has been successfully added to your 
